GO:0000987 cis-regulatory region sequence-specific DNA binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0000987 describes the molecular function of sequence-specific binding to cis-regulatory DNA elements such as enhancers, silencers, and proximal promoters.
• This activity is the first step in context-specific transcriptional regulation, enabling transcription factors to interpret genomic regulatory information.
• Binding specificity is not determined by the DNA motif alone; chromatin context, cofactor interactions, and flanking sequences strongly influence occupancy.
• Steroid hormone receptors are classic examples of sequence-specific cis-regulatory DNA-binding proteins that link hormonal signals to gene expression programs.
• Disruption of cis-regulatory DNA binding is implicated in cancer, developmental disorders, and hemoglobinopathies.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models allow causal testing of cis-regulatory DNA-binding proteins and their binding sites.
Description
GO:0000987, cis-regulatory region sequence-specific DNA binding, is a molecular function that describes the selective interaction of a protein with a defined DNA sequence located upstream of a transcription start site on the same DNA strand. These cis-regulatory elements include enhancers, silencers, and proximal promoter motifs that collectively encode the regulatory logic of a gene. The function is essential for converting extracellular and intracellular signals into precise, context-dependent gene expression programs. Researchers study this activity because it sits at the interface between genome sequence and transcriptional output. Sequence-specific DNA binding by transcription factors is the initial event that recruits coactivators or corepressors and ultimately determines whether a gene is active or silent in a given cell type. Understanding this function therefore informs developmental biology, immunology, cancer biology, and synthetic biology. Advances in high-throughput binding assays, genome editing, and computational motif discovery have made it possible to map and perturb cis-regulatory DNA-binding events with increasing precision. This article summarizes the definition, mechanism, key proteins, disease links, and experimental strategies relevant to GO:0000987.
cis-regulatory region sequence-specific DNA binding At A Glance
| GO ID | GO:0000987 |
|---|---|
| GO term | cis-regulatory region sequence-specific DNA binding |
| Ontology | molecular_function |
| Synonym | cis-regulatory region binding; enhancer binding; core promoter proximal region sequence-specific DNA binding; proximal promoter sequence-specific DNA binding |
| Major function | Sequence-specific recognition of enhancer, silencer, or proximal promoter DNA elements to initiate context-dependent transcriptional regulation |
| Definition source | QuickGO definition based on cis-regulatory elements located upstream of a transcription start site on the same DNA strand |
| Biological context | Transcription factor occupancy at enhancers, silencers, and promoters; integration with coactivator and corepressor complexes |
| Representative proteins | Steroid hormone receptors, PURB, and many sequence-specific transcription factors that bind defined cis-regulatory motifs |
What Is GO:0000987?
GO:0000987 is defined as binding to a specific upstream regulatory DNA sequence, such as a transcription factor recognition sequence or binding site, located in cis relative to the transcription start site of a gene. In practice, this means a protein recognizes a short DNA motif within an enhancer, silencer, or proximal promoter and forms a stable, sequence-dependent complex. The term is a molecular function and is distinct from general DNA binding or from transcription factor activity, which additionally requires a regulatory effect on transcription.
Why Is cis-regulatory region sequence-specific DNA binding Important in Cell Biology?
Cis-regulatory region sequence-specific DNA binding is important because it is the molecular event that allows a finite set of transcription factors to generate the enormous diversity of gene expression patterns observed across cell types and developmental stages. Without this function, enhancers and silencers cannot be interpreted, and signals from hormones, growth factors, and stress pathways cannot be converted into appropriate transcriptional responses. Consequently, this activity is central to normal development, tissue homeostasis, and the pathogenesis of many human diseases.
• It provides the sequence-specific recognition step that initiates enhancer and promoter-driven transcription.
• It enables context-specific transcription factor binding, which is essential for cell-type identity and developmental transitions.
• It mediates hormonal regulation of gene expression, as exemplified by steroid hormone receptor binding to cis-regulatory elements.
• It is required for p53-dependent promoter-specific transcriptional activation through complexes such as PURB-HOTAIR.
• It underlies the interpretation of tissue-specific DNA sequence motifs discovered from mammalian gene expression data.
• It is a target for artificial zinc finger DNA-binding domains that can neutralize cis-regulatory elements.
• Dysregulation of cis-regulatory DNA binding contributes to cancer, developmental disorders, and hemoglobinopathies.
• It is a key consideration in CRISPR screens and bioinformatics pipelines that aim to link regulatory elements to gene function.
• It informs the design of synthetic regulatory circuits and targeted epigenetic editing strategies.
• It is a major source of non-coding variant interpretation challenges in human genetics.
What Happens During cis-regulatory region sequence-specific DNA binding?
Recognition of the cis-regulatory motif
In simple terms: A transcription factor scans DNA and finds a short sequence that matches its preferred binding motif.
The first step is sequence-specific recognition of a cis-regulatory element, such as an enhancer or proximal promoter motif, by the DNA-binding domain of a transcription factor. This recognition depends on the DNA sequence of the motif and on flanking sequences that can modulate affinity and specificity. Context-specific binding is often not fully explained by the motif alone, indicating that additional features contribute to occupancy.
Formation of a stable protein-DNA complex
In simple terms: Once the factor finds its site, it locks onto the DNA and forms a stable complex.
After initial recognition, the transcription factor forms a stable complex with the cis-regulatory DNA through hydrogen bonds, van der Waals contacts, and electrostatic interactions. The stability of this complex determines how long the factor remains bound and influences its ability to recruit cofactors. Steroid hormone receptors exemplify this step, binding to hormone response elements in a ligand-dependent manner.
Recruitment of coregulators and chromatin modifiers
In simple terms: The bound factor then calls in helper proteins that modify chromatin and turn transcription up or down.
Sequence-specific DNA binding is coupled to the recruitment of transcription coregulator complexes, including coactivators and corepressors that modify chromatin and interact with the basal transcription machinery. Integration of coregulator complexes with sequence-specific DNA-binding factor interactomes determines the regulatory outcome at a given element. This step links cis-regulatory DNA binding to changes in histone modifications and chromatin accessibility.
Context-dependent regulation of binding
In simple terms: Whether a factor actually binds in a real cell depends on the cell type, chromatin state, and partner proteins.
In vivo occupancy is context-specific and can differ from in vitro motif preferences because chromatin accessibility, cooperative interactions, and competing factors influence binding. Meta-analysis of mammalian gene expression data has revealed tissue-specific DNA sequence motifs that reflect these context-dependent requirements. Therefore, cis-regulatory region sequence-specific DNA binding must be interpreted within the cellular and chromatin context.
Key Genes Involved in GO:0000987 cis-regulatory region sequence-specific DNA binding
The following proteins represent major examples of sequence-specific cis-regulatory DNA-binding factors and related regulators discussed in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PURB | Sequence-specific DNA-binding protein that forms a complex with HOTAIR and regulates p53-dependent promoter-specific activation | Studied for promoter-specific transcriptional activation and cancer-related p53 pathways |
| HOTAIR | Long non-coding RNA that interacts with PURB to modulate promoter-specific transcription | Investigated as a regulator of p53-dependent transcriptional programs |
| TP53 | Tumor suppressor transcription factor whose activity is linked to promoter-specific activation complexes | Central to cancer biology and p53-dependent transcriptional responses |
| ESR1 | Estrogen receptor, a steroid hormone receptor that binds cis-regulatory elements | Model for hormone-dependent cis-regulatory DNA binding and breast cancer research |
| AR | Androgen receptor, a steroid hormone receptor with sequence-specific DNA-binding activity | Studied in prostate cancer and androgen signaling |
| GR | Glucocorticoid receptor that binds hormone response elements | Classic model for ligand-dependent cis-regulatory DNA binding |
| NR3C1 | Gene encoding the glucocorticoid receptor | Used in studies of steroid hormone regulation of transcription |
| NR3C2 | Gene encoding the mineralocorticoid receptor | Relevant to aldosterone-regulated gene expression |
| PGR | Progesterone receptor that binds progesterone response elements | Studied in reproductive biology and hormone-responsive cancers |
| HBB | Beta-globin gene with a well-characterized cis-regulatory element | Target for artificial zinc finger DNA-binding domain studies |
| ZFP | Artificial zinc finger DNA-binding domain used to neutralize a beta-globin-associated cis-regulatory element | Demonstrates programmable targeting of cis-regulatory DNA |
| GATA1 | Erythroid transcription factor that binds cis-regulatory elements in globin loci | Relevant to hemoglobinopathy research and erythroid gene regulation |
| NF-kB | Sequence-specific transcription factor family that binds enhancer elements | Studied in inflammation and immune gene regulation |
| STAT | Signal transducer and activator of transcription family that binds specific promoter motifs | Model for cytokine-induced cis-regulatory DNA binding |
| MYC | Transcription factor that binds enhancer and promoter elements | Studied in cancer and cell proliferation |
| SP1 | GC-box binding transcription factor | Classic example of proximal promoter sequence-specific DNA binding |
| CTCF | Insulator protein that binds specific DNA sequences | Studied for chromatin architecture and enhancer blocking |
| TFAP2 | Transcription factor family with context-specific cis-regulatory binding | Used in studies of context-specific binding requirements |
How Is cis-regulatory region sequence-specific DNA binding Regulated?
The activity of cis-regulatory region sequence-specific DNA binding is regulated at multiple levels. Ligand availability controls the binding of steroid hormone receptors to their response elements, as shown for glucocorticoid, estrogen, androgen, and progesterone receptors. Chromatin accessibility and cooperative interactions with other DNA-binding proteins further modulate whether a factor can occupy its motif in a given cell type. In addition, integration with transcription coregulator complexes determines the functional consequence of binding, converting occupancy into activation or repression. Post-translational modifications and non-coding RNA interactions, such as the PURB-HOTAIR complex, can also influence promoter-specific DNA binding and transcriptional activation.
cis-regulatory region sequence-specific DNA binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PURB | Cancer and p53-dependent transcriptional activation | Knockout or overexpression of PURB in cancer cell lines followed by promoter-specific reporter assays |
| HBB | Beta-globin-associated hemoglobinopathies | Point mutation or knock-in of the cis-regulatory element in erythroid cells, with artificial zinc finger neutralization |
| ESR1 | Hormone-dependent breast cancer | Point mutation of the DNA-binding domain or knockout in breast cancer cell lines |
| AR | Prostate cancer and androgen signaling | Knockout or point mutation in prostate cancer models |
| GR (NR3C1) | Endocrine and metabolic disorders | Knockout or point mutation in cell lines to test hormone response element binding |
Cancer and p53-dependent transcription
Sequence-specific cis-regulatory DNA binding is directly implicated in cancer through complexes such as PURB-HOTAIR, which regulates p53-dependent promoter-specific transcriptional activation. Disruption of such binding events can alter tumor suppressor or oncogene expression programs. Because p53 is a central tumor suppressor, understanding how cis-regulatory DNA-binding complexes modulate its target promoters is important for cancer research.
Hemoglobinopathies and beta-globin regulation
The beta-globin locus contains well-characterized cis-regulatory elements, and artificial zinc finger DNA-binding domains have been used to neutralize a beta-globin-associated cis-regulatory DNA element. This demonstrates that perturbing sequence-specific cis-regulatory DNA binding can affect globin gene expression, with implications for hemoglobinopathies such as sickle cell disease and beta-thalassemia.
Hormone-dependent diseases
Steroid hormone receptors bind cis-regulatory elements to regulate gene expression, and this activity is central to hormone-dependent cancers and endocrine disorders. Estrogen receptor, androgen receptor, glucocorticoid receptor, and progesterone receptor are all sequence-specific DNA-binding factors whose dysregulation contributes to disease. Studying their cis-regulatory binding is therefore relevant to breast cancer, prostate cancer, and metabolic disorders.
Developmental and non-coding variant disorders
Context-specific transcription factor binding depends on cis-regulatory sequence requirements, and variants that alter these sequences can disrupt normal developmental gene expression. Meta-analysis of tissue-specific DNA sequence motifs has helped identify regulatory elements that may harbor disease-associated variants. As a result, cis-regulatory DNA binding is a key consideration in interpreting non-coding genetic variation in developmental disorders.
From cis-regulatory region sequence-specific DNA binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate transcription factor directly bind a specific cis-regulatory element? | Knockout of the factor combined with chromatin immunoprecipitation and reporter assays |
| Which DNA base pairs are required for sequence-specific binding? | Point mutation of the cis-regulatory motif in a reporter construct or endogenous locus |
| Can a disease-associated non-coding variant alter factor occupancy? | Knock-in of the variant allele followed by allele-specific binding assays |
| Where does a factor bind genome-wide in a given cell type? | Tagged knock-in of the factor followed by ChIP-seq or CUT&RUN |
| Does overexpression of a factor change target gene expression? | Overexpression cell model with RNA-seq and differential expression analysis |
| Can an artificial DNA-binding domain neutralize a cis-regulatory element? | Zinc finger or CRISPR-based targeting of the element in relevant cell lines |
How to Study the cis-regulatory region sequence-specific DNA binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ChIP-seq | Genome-wide occupancy of a DNA-binding factor | Mapping enhancer and promoter binding sites |
| CUT&RUN | Low-input genome-wide binding profiles | Studying rare cell populations or limited material |
| Reporter assay | Transcriptional activity driven by a cis-regulatory element | Testing motif necessity and sufficiency |
| EMSA | In vitro protein-DNA complex formation | Validating direct sequence-specific binding |
| Motif discovery | Overrepresented DNA sequences in regulatory regions | Identifying candidate cis-regulatory motifs |
| RNA-seq | Changes in gene expression after perturbation | Linking binding to transcriptional output |
| CRISPR screen | Phenotypic effects of perturbing regulatory elements or factors | Functional genomics of cis-regulatory DNA binding |
| Bioinformatics integration | Combined analysis of binding, expression, and sequence data | Prioritizing regulatory variants and networks |
Chromatin immunoprecipitation and binding assays
Chromatin immunoprecipitation followed by sequencing (ChIP-seq) or related methods such as CUT&RUN are used to map genome-wide occupancy of sequence-specific DNA-binding factors at cis-regulatory elements. These assays reveal which enhancers and promoters are bound in a given cell type and how binding changes with perturbations. They are often combined with motif analysis to identify enriched cis-regulatory sequences.
Reporter assays and motif perturbation
Reporter assays with wild-type or mutated cis-regulatory elements are used to test whether a specific motif is necessary and sufficient for sequence-specific DNA binding and transcriptional regulation. Point mutations within the motif can abolish binding and reduce reporter activity, providing causal evidence for the element's function. Such assays are foundational for studying GO:0000987 in a controlled context.
Computational motif discovery and meta-analysis
Computational approaches identify overrepresented DNA sequence motifs from gene expression or binding data, revealing tissue-specific and context-specific cis-regulatory requirements. Meta-analysis of mammalian gene expression data has been used to discover tissue-specific DNA sequence motifs. These methods help prioritize candidate cis-regulatory elements for experimental validation.
CRISPR-based perturbation and functional genomics
CRISPR knockout, point mutation, knock-in, and overexpression models allow direct testing of the causal role of a DNA-binding factor or its cognate cis-regulatory element. Pooled CRISPR screens combined with bioinformatics can link regulatory elements to gene expression and phenotype. These approaches are increasingly used to dissect cis-regulatory DNA-binding networks.
How CRISPR Can Be Used to Study GO:0000987 cis-regulatory region sequence-specific DNA binding
Knockout
CRISPR knockout of a gene encoding a sequence-specific DNA-binding factor can abolish its cis-regulatory binding and reveal downstream transcriptional consequences. Knockout models are useful for testing whether a factor is required for enhancer or promoter activity in a given cell type. They are often combined with RNA-seq and ChIP-seq to define the regulatory network controlled by the factor.
Point Mutation
CRISPR point mutation can be used to alter specific base pairs within a cis-regulatory motif or within the DNA-binding domain of a factor. This allows precise testing of which nucleotides are required for sequence-specific binding and transcriptional regulation. Point-mutation models are particularly valuable for interpreting non-coding variants associated with disease.
Knock-in
CRISPR knock-in can introduce a tagged version of a DNA-binding factor or a disease-associated variant into the endogenous locus. Tagged knock-in enables allele-specific binding assays and genome-wide occupancy mapping without overexpression artifacts. Knock-in of regulatory variants allows direct comparison of binding and expression between alleles.
Overexpression
CRISPR-based overexpression or cDNA overexpression of a sequence-specific DNA-binding factor can test whether increased factor levels alter target gene expression. Overexpression models are useful for studying gain-of-function effects and for identifying direct target genes. They should be interpreted alongside physiological occupancy data to avoid artifacts from non-physiological factor levels.
How EDITGENE Supports cis-regulatory region sequence-specific DNA binding Research
Researchers studying cis-regulatory region sequence-specific DNA binding-related genes often need to determine whether a candidate gene is causally involved in a regulatory or disease phenotype. This requires precise, reproducible cell models that can isolate the contribution of a single factor or a single cis-regulatory element. EDITGENE provides a comprehensive suite of CRISPR-based services designed to support such causal studies.
Contact EDITGENE today to design your custom CRISPR model for cis-regulatory region sequence-specific DNA binding research.
Frequently Asked Questions About cis-regulatory region sequence-specific DNA binding
What is GO:0000987?
GO:0000987 is the Gene Ontology molecular function term for cis-regulatory region sequence-specific DNA binding, which describes binding to a specific upstream regulatory DNA sequence such as an enhancer, silencer, or proximal promoter motif.
What genes are involved in cis-regulatory region sequence-specific DNA binding?
Genes encoding sequence-specific transcription factors such as PURB, ESR1, AR, GR (NR3C1), PGR, SP1, CTCF, and many others are involved in this function.
How does cis-regulatory region sequence-specific DNA binding work?
A transcription factor recognizes a short DNA motif in a cis-regulatory element, forms a stable protein-DNA complex, and recruits coregulators that modify chromatin and regulate transcription.
Why is cis-regulatory region sequence-specific DNA binding important?
It is the initial step that converts genomic regulatory information into context-specific gene expression programs, and its dysregulation is linked to cancer, hemoglobinopathies, and developmental disorders.
What diseases are associated with defects in cis-regulatory DNA binding?
Diseases include cancer through p53-dependent pathways, beta-globin-associated hemoglobinopathies, and hormone-dependent cancers involving steroid hormone receptors.
How can I study cis-regulatory region sequence-specific DNA binding in the lab?
Common methods include ChIP-seq, CUT&RUN, reporter assays, EMSA, motif discovery, RNA-seq, and CRISPR-based perturbation of factors or elements.
What is the difference between cis-regulatory region sequence-specific DNA binding and general DNA binding?
Sequence-specific binding requires recognition of a defined motif in a cis-regulatory element, whereas general DNA binding may lack sequence specificity and does not necessarily regulate transcription.
Can CRISPR be used to study cis-regulatory DNA binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to perturb DNA-binding factors or their cognate cis-regulatory elements and measure transcriptional consequences.
What are examples of cis-regulatory elements?
Enhancers, silencers, and proximal promoter motifs are common cis-regulatory elements that are bound by sequence-specific DNA-binding factors.
How does context affect cis-regulatory DNA binding?
Binding is context-specific because chromatin accessibility, cooperative interactions, and partner proteins influence whether a factor occupies its motif in a given cell type.
Conclusion
GO:0000987, cis-regulatory region sequence-specific DNA binding, is a fundamental molecular function that links DNA sequence to context-specific transcriptional regulation. It is mediated by sequence-specific transcription factors that recognize enhancers, silencers, and proximal promoters and recruit coregulators to modulate gene expression. Dysregulation of this activity contributes to cancer, hemoglobinopathies, and hormone-dependent diseases, making it a key area of biomedical research. Advances in CRISPR-based cell modeling, genome-wide binding assays, and computational motif discovery continue to improve our ability to dissect cis-regulatory DNA-binding events. Researchers can now test causal relationships between specific factors, cis-regulatory elements, and disease phenotypes with increasing precision. EDITGENE supports these efforts with tailored knockout, point-mutation, knock-in, overexpression, library-screening, and bioinformatics services.
References
- 1. Yáñez-Cuna JO et al.. 2012. Uncovering cis-regulatory sequence requirements for context-specific transcription factor binding.. Genome Res 22(10):2018-30 PMID: 22534400
- 2. Inukai S et al.. 2017. Transcription factor-DNA binding: beyond binding site motifs.. Curr Opin Genet Dev 43:110-119 PMID: 28359978
- 3. Beato M et al.. 1996. Transcriptional regulation by steroid hormones.. Steroids 61(4):240-51 PMID: 8733009
- 4. Xia Z et al.. 2025. The PURB-HOTAIR complex regulates p53-dependent promoter-specific transcriptional activation.. Nat Struct Mol Biol 32(9):1669-1682 PMID: 40563010
- 5. Franco-Zorrilla JM et al.. 2017. Identification of plant transcription factor target sequences.. Biochim Biophys Acta Gene Regul Mech 1860(1):21-30 PMID: 27155066
- 6. Velthuijs N et al.. 2021. Integration of transcription coregulator complexes with sequence-specific DNA-binding factor interactomes.. Biochim Biophys Acta Gene Regul Mech 1864(10):194749 PMID: 34425241
- 7. Huber BR et al.. 2006. Meta-analysis discovery of tissue-specific DNA sequence motifs from mammalian gene expression data.. BMC Bioinformatics 7:229 PMID: 16643658
- 8. Barrow JJ et al.. 2012. Neutralizing the function of a β-globin-associated cis-regulatory DNA element using an artificial zinc finger DNA-binding domain.. Proc Natl Acad Sci U S A 109(44):17948-53 PMID: 23074246
